Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigms.

被引：68

作者：

Plutzky J. ^{[1
]}

机构：

[1] Cardiovascular Division, Department of Medicine, LMRC 307, Brigham and Women's Hospital, 221 Longwood Avenue, Boston, 02115, MA

来源：

Current Atherosclerosis Reports | 2000年 / 2卷 / 4期

关键词：

Rosiglitazone; Fenofibrate; Troglitazone; Peroxisome Proliferator; Arterioscler Thromb Vasc Biol;

D O I：

10.1007/s11883-000-0067-3

中图分类号：

学科分类号：

摘要：

Peroxisome Proliferator-Activated Receptors (PPARs), members of the steroid hormone nuclear receptor superfamily, act as ligand-activated transcription factors controlling the expression of specific target genes. Known PPAR isoforms include PPAR gamma, important in adipogenesis and lipid metabolism, PPAR alpha, implicated in fatty acid metabolism, and PPAR delta, about which the least is known. Recent work implicates PPAR alpha and gamma in vascular biology and atherosclerosis, and will be reviewed here. Such effects may have clinical implications given PPAR agonists in use as pharmacologic agents (eg, thiazolidinediones as insulin sensitizers [gamma] and fibric acids as lipid lowering agents [alpha]).

引用

页码：327 / 335

页数：8

共 286 条

[1]

Fickett JW(2000)Discovery and modeling of transcriptional regulatory regions Curr Opin Biotechnol 11 19-24

[2]

Wasserman WW(2000)Cardiovascular gene therapy Lancet 355 213-222

[3]

Yla-Herttuala S(1999)Atherosclerosis — an inflammatory disease N Eng J Med 340 115-126

[4]

Martin JF(1995)Molecular bases of the acute coronary syndromes Circulation 91 2844-2850

[5]

Ross R(1999)A spatial approach to transcriptional profiling: mechanotransduction and the focal origin of atherosclerosis Trends Biotechnol 17 347-351

[6]

Libby P(1999)Vascular-bed-specific hemostasis and hypercoagulable states N Engl J Med 340 1555-1564

[7]

Davies PF(1999)Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation Mol Cell Biochem 190 105-118

[8]

Polacek DC(2000)Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases Pharmacol Rev 52 11-34

[9]

Handen JS(1998)PPAR-gamma: adipogenic regulator and thiazolidinedione receptor Diabetes 47 507-514

[10]

Rosenberg RD(1997)Thiazolidinediones Endocrinol Metab Clin North Am 26 553-573

← 1 2 3 4 5 6 7 8 9 10 →